Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Plos Neglected Tropical Diseases|March 10, 2018
Development of a reverse genetics system for Sosuga virus allows rapid screening of antiviral compoundsStephen R Welch, Ayan K Chakrabarti, Lisa Wiggleton Guerrero, et al.
Antiviral Research|November 5, 2013
Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamstersMichael K Lo, Brian H Bird, Anasuya Chattopadhyay, et al.
Antiviral Research|June 18, 2026
Potent In Vitro Antiviral Activity of 4'-Fluorouridine Against Diverse Orthohantaviruses including Andes VirusPunya Shrivastava-Ranjan, Laura K McMullan, Shannon L Whitmer, et al.
Biorxiv : the Preprint Server for Biology|August 17, 2021
Broad-spectrum in vitro antiviral activity of ODBG-P-RVn: an orally-available, lipid-modified monophosphate prodrug of remdesivir parent nucleoside (GS-441524)Michael K Lo, Punya Shrivastava-Ranjan, Payel Chatterjee, et al.
Journal of Virological Methods|June 30, 2009
Development of a neutralization assay for Nipah virus using pseudotype particlesAzaibi Tamin, Brian H Harcourt, Michael K Lo, et al.
Antiviral Research|January 15, 2020
Potent in vitro activity of β-D-4'-chloromethyl-2'-deoxy-2'-fluorocytidine against Nipah virusMichael K Lo, Franck Amblard, Mike Flint, et al.
The Journal of Infectious Diseases|October 31, 2019
In Situ Imaging of Fluorescent Nipah Virus Respiratory and Neurological Tissue Tropism in the Syrian Hamster ModelStephen R Welch, Florine E M Scholte, Jessica R Harmon, et al.
Microbiology Spectrum|November 24, 2021
Broad-Spectrum In Vitro Antiviral Activity of ODBG-P-RVn: An Orally-Available, Lipid-Modified Monophosphate Prodrug of Remdesivir Parent Nucleoside (GS-441524)Michael K Lo, Punya Shrivastava-Ranjan, Payel Chatterjee, et al.
Scientific Reports|July 14, 2023
Immunogenicity of poxvirus-based vaccines against Nipah virusEmily S Medina-Magües, Jaime Lopera-Madrid, Michael K Lo, et al.
Nature Communications|January 19, 2019
A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virusMike Flint, Payel Chatterjee, David L Lin, et al.
Pageof 8